Choosing the right timing for interval debulking surgery and perioperative chemotherapy may improve the prognosis of advanced epithelial ovarian cancer: a retrospective study

BACKGROUND: Primary debulking surgery (PDS) is the main treatment for patients with advanced ovarian cancer, and neoadjuvant chemotherapy (NACT) is for bulky stage III-IV patients who are poor surgical candidates and/or for whom there is a low likelihood of optimal cytoreduction. NACT can increase t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dengfeng, Zhang, Guonan, Peng, Chunrong, Shi, Yu, Shi, Xunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004423/
https://www.ncbi.nlm.nih.gov/pubmed/33771198
http://dx.doi.org/10.1186/s13048-021-00801-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004423/
https://www.ncbi.nlm.nih.gov/pubmed/33771198
http://dx.doi.org/10.1186/s13048-021-00801-4

Ejemplares similares